Analysis of Volatile Organic Compounds of Bacterial Origin in Chronic Gastrointestinal Diseases

Background: The aim of this study was to determine whether volatile organic compounds (VOCs) present in the headspace of feces could be used to diagnose or distinguish between chronic diseases of the gastrointestinal tract and apparently healthy volunteers. Methods: A total of 87 people were recruited, divided between 4 categories: healthy volunteers (n = 19), Crohn’s disease (n = 22), ulcerative colitis (n = 20), and irritable bowel syndrome (n = 26). They each supplied fecal samples before, and except for the healthy volunteers, after treatment. Fecal samples were incubated in a sample bag with added purified air at 40°C and headspace samples were taken and concentrated on thermal sorption tubes. Gas chromatography–mass spectrometry then desorbed and analyzed these. The concentrations of a selection of high-abundance compounds were determined and assessed for differences in concentration between the groups. Results: Crohn's disease samples showed significant elevations in the concentrations of ester and alcohol derivates of short-chain fatty acids and indole compared with the other groups; indole and phenol were elevated in ulcerative colitis and irritable bowel syndrome but not at a statistically significant level. After treatment, the levels of many of the VOCs were significantly reduced and were more similar to those concentrations in healthy controls. Conclusions: The abundance of a number of VOCs in feces differs markedly between Crohn's disease and other gastrointestinal conditions. Following treatment, the VOC profile is altered to more closely resemble that of healthy volunteers.

[1]  S. Siegel,et al.  Nonparametric Statistics for the Behavioral Sciences , 2022, The SAGE Encyclopedia of Research Design.

[2]  C. W. Moss,et al.  Determination of volatile acid production of Clostridium by gas chromatography. , 1967, Canadian journal of microbiology.

[3]  J. Bartlett,et al.  Rapid diagnosis of anaerobic infections by direct gas-liquid chromatography of clinical speciments. , 1976, The Journal of clinical investigation.

[4]  K. Phillips,et al.  Rapid diagnosis of anaerobic infections by gas-liquid chromatography of clinical material. , 1976, Journal of clinical pathology.

[5]  P. Murray,et al.  Rapid presumptive identification of anaerobes in blood cultures by gas-liquid chromatography , 1980, Journal of clinical microbiology.

[6]  B. Sobel,et al.  Mitochondrial dysfunction induced by fatty acid ethyl esters, myocardial metabolites of ethanol. , 1983, The Journal of clinical investigation.

[7]  A. Euler.  FOOD INTOLERANCE: A MAJOR FACTOR IN THE PATHOGENESIS OF IRRITABLE BOWEL SYNDROME , 1983 .

[8]  T. Maudelonde,et al.  The Lancet: saturday 11 November 1989 , 1989 .

[9]  D. Jewell,et al.  Food intolerance and the irritable bowel syndrome. , 1989, Gut.

[10]  R. E. Cowan,et al.  Treatment of active Crohn's disease by exclusion diet: East Anglian Multicentre Controlled Trial , 1993, The Lancet.

[11]  A. Riordan,et al.  Management of patients with food intolerance in irritable bowel syndrome: the development and use of an exclusion diet , 1995 .

[12]  K. Ewe,et al.  Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease (IBD) , 1995, Clinical and experimental immunology.

[13]  P. Mortensen,et al.  Short-chain fatty acids in the human colon: relation to gastrointestinal health and disease. , 1996, Scandinavian journal of gastroenterology. Supplement.

[14]  G. Macfarlane,et al.  Dissimilatory amino Acid metabolism in human colonic bacteria. , 1997, Anaerobe.

[15]  S. Molin,et al.  Volatile metabolites from some gram-negative bacteria. , 1997, Chemosphere.

[16]  M. Elia,et al.  Abnormal colonic fermentation in irritable bowel syndrome , 1998, The Lancet.

[17]  M. Levitt,et al.  Identification of gases responsible for the odour of human flatus and evaluation of a device purported to reduce this odour , 1998, Gut.

[18]  Naresh Magan,et al.  Use of an electronic nose system for diagnoses of urinary tract infections. , 2002, Biosensors & bioelectronics.

[19]  M. Pimentel.  Validation of an objective bowel composite score for IBS in studies involving treatment , 2002 .

[20]  M. Laposata,et al.  Fatty acid ethyl esters: toxic non-oxidative metabolites of ethanol and markers of ethanol intake. , 2003, Frontiers in bioscience : a journal and virtual library.

[21]  J. Lupton.  Microbial degradation products influence colon cancer risk: the butyrate controversy. , 2004, The Journal of nutrition.

[22]  L. A. van der Waaij,et al.  Immunoglobulin coating of faecal bacteria in inflammatory bowel disease , 2004, European journal of gastroenterology & hepatology.

[23]  C. Probert,et al.  A novel method for rapidly diagnosing the causes of diarrhoea , 2003, Gut.

[24]  W. Pollock,et al.  Bacteria produce the volatile hydrocarbon isoprene , 1995, Current Microbiology.

[25]  E. Kuipers,et al.  The Metabolic Activity of Fecal Microbiota from Healthy Individuals and Patients with Inflammatory Bowel Disease , 2004, Digestive Diseases and Sciences.

[26]  Naresh Magan,et al.  Detection of Mycobacterium tuberculosis (TB) in vitro and in situ using an electronic nose in combination with a neural network system. , 2004, Biosensors & bioelectronics.

[27]  D. Hassett,et al.  The Transcriptional Regulator AlgR Controls Cyanide Production in Pseudomonas aeruginosa , 2004, Journal of bacteriology.

[28]  F. Bäckhed,et al.  Host-Bacterial Mutualism in the Human Intestine , 2005, Science.

[29]  M. Elia,et al.  Do Interventions Which Reduce Colonic Bacterial Fermentation Improve Symptoms of Irritable Bowel Syndrome? , 2005, Digestive Diseases and Sciences.

[30]  Josef Rieder,et al.  Mass spectrometric profiling of low-molecular-weight volatile compounds--diagnostic potential and latest applications. , 2007, Current medicinal chemistry.

[31]  Ben Lacy Costello,et al.  The FASEB Journal • Research Communication Volatile organic compounds from feces and their potential for diagnosis of gastrointestinal disease , 2022 .

[32]  Tomas Mikoviny,et al.  On-Line Monitoring of Microbial Volatile Metabolites by Proton Transfer Reaction-Mass Spectrometry , 2008, Applied and Environmental Microbiology.

[33]  R Balfour Sartor,et al.  Microbial influences in inflammatory bowel diseases. , 2008, Gastroenterology.

[34]  P. Elliott,et al.  The UK Biobank sample handling and storage protocol for the collection, processing and archiving of human blood and urine. , 2008, International journal of epidemiology.

[35]  Paul Elliott,et al.  The UK Biobank sample handling and storage validation studies. , 2008, International journal of epidemiology.

[36]  William L. Cody,et al.  Pseudomonas aeruginosa AlgR Controls Cyanide Production in an AlgZ-Dependent Manner , 2009, Journal of bacteriology.

[37]  P. Rutgeerts,et al.  Development of a screening method to determine the pattern of fermentation metabolites in faecal samples using on-line purge-and-trap gas chromatographic-mass spectrometric analysis. , 2006, Journal of chromatography. A.

[38]  P. Lepage,et al.  Transcriptional activity of the dominant gut mucosal microbiota in chronic inflammatory bowel disease patients. , 2010, Journal of medical microbiology.

[39]  P. Bork,et al.  A human gut microbial gene catalogue established by metagenomic sequencing , 2010, Nature.

[40]  Petra Reinhold,et al.  Chronic intestinal Mycobacteria infection: discrimination via VOC analysis in exhaled breath and headspace of feces using differential ion mobility spectrometry , 2011, Journal of breath research.

[41]  A. Darzi,et al.  Gut microbiome-host interactions in health and disease , 2011, Genome Medicine.

[42]  Richard Hansen,et al.  IBD—what role do Proteobacteria play? , 2012, Nature Reviews Gastroenterology &Hepatology.

[43]  K. Verbeke,et al.  Functional analysis of colonic bacterial metabolism: relevant to health? , 2012, American journal of physiology. Gastrointestinal and liver physiology.

[44]  Y. Ringel,et al.  Alterations in composition and diversity of the intestinal microbiota in patients with diarrhea‐predominant irritable bowel syndrome , 2012, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[45]  R. Knight,et al.  Diversity, stability and resilience of the human gut microbiota , 2012, Nature.